• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Contact


Email

joliaro@unimelb.edu.au

Credentials


Position
Honorary Conjoint Professorial Fellow
The Sir Peter MacCallum Department of Oncology
Education
PhD
Massey University
Bachelors Degree (Honours)
Monash University
ORCID

0000-0002-2097-6428

Prof Jane Oliaro

Honorary Conjoint Professorial Fellow
The Sir Peter MacCallum Department of Oncology

74 Scholarly works
18 Projects

HIGHLIGHTS

  • 2026

    Research grants (international)

    Using Novel Biological Therapies to Target a Tumor-Specific Isoform of HER2 for the Treatment of Advanced Breast Cancer.
  • 2026

    Journal article

    CDK4/6 inhibition enhances CAR-T cell therapy in solid tumors
    DOI: 10.1016/j.ymthe.2026.03.024
  • 2025

    Journal article

    Targeting PTPN2 enhances human CAR T cell efficacy and the development of long-term memory in mouse xenograft models
    DOI: 10.1126/scitranslmed.adk0627
  • 2025

    Journal article

    Rewiring endogenous genes in CAR T cells for tumour-restricted payload delivery
    DOI: 10.1038/s41586-025-09212-7
  • 2025

    Journal article

    423 | ctDNA‐DIRECTED INTERVENTION WITH EPCORITAMAB ALONE OR IN COMBINATION WITH LENALIDOMIDE‐RITUXIMAB IS FEASIBLE IN THE EARLY POST‐CAR‐T POPULATION AT HIGH RISK OF RELAPSE
    DOI: 10.1002/hon.70094_423
  • 2021

    Research grants (ARC, NHMRC, MRFF)

    Studying the Origins, Maintenance and Resistance Mechanisms of Poor Risk Paediatric Leukaemia at Single Cell Resolution to Develop Novel Therapeutic Approaches
  • 2018

    Research Grant

    Novel Therapies to Enhance Anti-Tumour Immunity
Jane Oliaro

Latest Honours,
Awards and Fellowships


1995
Rose Catherine Memorial Scholarship for Cancer Research

RECENT SCHOLARLY WORKS

  • 2025

    Journal article

    CAR T-Cell Lymphoma after Cilta-cel Therapy for Relapsed or Refractory Myeloma
    DOI: 10.1056/NEJMoa2309728
  • 2024

    Journal article

    Intracellular zinc protects tumours from T cell-mediated cytotoxicity
    DOI: 10.1038/s41418-024-01369-4
  • 2024

    Journal article

    CAR-T Cell Therapy in Advanced Myeloma with Extramedullary Disease - an In Vivo Imaging and Molecular Monitoring Study (CARAMEL): First Results of Cu-64 Radiolabelled Nanoparticle PET-CT and PET-MRI
    DOI: 10.1182/blood-2024-210017
  • 2024

    Journal article

    FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy
    DOI: 10.1038/s41586-024-07242-1
  • 2023

    Conference Proceedings

    A Novel CAR-T cell therapy targeting kappa myeloma antigen for the treatment of multiple myeloma
    DOI: 10.1016/s2152-2650(23)01633-6
  • 2023

    Conference Proceedings

    Cellular immunotherapy targeting kappa myeloma antigen for the treatment of multiple myeloma
    DOI: 10.1158/1538-7445.AM2023-4074

RECENT PROJECTS

  • 2023

    Research grants (other domestic)

    Developing Next Generation Armoured CAR-T Cells for the Treatment
  • 2026

    Research grants (other domestic)

    Development of a Novel Nanobody-Secreting CAR-T Cell for the Treatment of Multiple Myeloma

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated

Read about our commitment to reconciliation  

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia


View all Campus locations  
facebookIconlinkedinIconinstagramIcontwitterIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy  |  VaxFACTS

CRICOS number: 00116K     ABN: 84 002 705 224